Literature DB >> 22381910

Infective endocarditis presenting as ST-elevation myocardial infarction: an angiographic diagnosis.

Benjamin Hibbert1, Mustapha Kazmi, John P Veinot, Edward R O'Brien, Christopher Glover.   

Abstract

While systemic embolic events occur with relative frequency in infective endocarditis (IE), coronary embolization remains an uncommon cause of ST elevation myocardial infarction. Herein we report a case of ventricular fibrillation and anterior ST elevation myocardial infarction occurring in a patient initially presenting with septic shock. Angiography proved diagnostic for IE of a native bicuspid aortic valve complicated by root abscess and left anterior descending artery occlusion. Histologic examination of the embolectomy specimen from the left anterior descending artery confirmed the presence of thrombus and bacteria. The present case highlights difficulties in identifying and managing patients with coronary embolism of vegetations from IE.
Copyright © 2012 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22381910     DOI: 10.1016/j.cjca.2012.01.006

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  3 in total

Review 1.  Role of complement C5a and histones in septic cardiomyopathy.

Authors:  Fatemeh Fattahi; Lynn M Frydrych; Guowu Bian; Miriam Kalbitz; Todd J Herron; Elizabeth A Malan; Matthew J Delano; Peter A Ward
Journal:  Mol Immunol       Date:  2018-06-18       Impact factor: 4.407

2.  Infective Aortic Valve Endocarditis Causing Embolic Consecutive ST-Elevation Myocardial Infarctions.

Authors:  Kanksha Peddi; Alexander L Hsu; Tomas H Ayala
Journal:  Case Rep Cardiol       Date:  2019-10-14

3.  ST segment elevation caused by ostial right coronary artery obstruction in infective endocarditis: a case report.

Authors:  Alexander Bolton; Georges Hajj; Laila Payvandi; Christopher Komanapalli
Journal:  BMC Cardiovasc Disord       Date:  2020-09-11       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.